Scotiabank analyst George Farmer lowered the firm’s price target on Syndax (SNDX) to $18 from $23 and keeps a Sector Perform rating on ...

To date, briquilimab has a demonstrated efficacy and safety profile in more than 160 dosed participants and healthy ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 – – Data from the Phase 2a Trial of SLS009 in ...

(Courtesy of Texas Children's Hospital) At Texas Children's Hospital, Fivecoat's daughter Shelly McAfee and her husband Tyler ...

Veteran NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year, the National Basketball Referees ...

In August, Syros discontinued enrollment in the Phase II SELECT-AML-1 trial, in which it was evaluating a triplet regimen of tamibarotene with venetoclax and azacitidine in newly diagnosed, unfit ...

Hematopoietic stem cell transplant (HSCT) after first complete remission appears more effective than non-HSCT consolidation in older patients with AML.

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

I was diagnosed with acute myeloid leukemia, and the prognosis was not good. I was given just a few months to live. The only ...

The response rate in the control cohort is in line with historical data on azacitidine. Investors, already burnt by setbacks ...